Articles From: Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case to Identive Group to Hold Second Quarter 2013 Conference Call and Webcast August 14, 2013


2014/3/24
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it intends to file an appeal to challenge the Oslo, Norway District Court's (the "Court") decision in a patent invalidity case concerning Idenix's co-owned Norwegian patent NO 330 755 that covers certain 2'-methyl-2'-fluoro nucleoside compounds useful in the treatment of the hepatitis C virus (HCV) and other flaviviridae infections.
Sign-up for Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case investment picks
2014/2/27
CAMBRIDGE, Mass., Feb.
Sign-up for Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results investment picks
2013/8/7
CAMBRIDGE, Mass., Aug.
Sign-up for Idenix Pharmaceuticals Reports Second Quarter and Six Month 2013 Financial Results investment picks
2013/10/30
-- Enrollment initiated for a phase I/II clinical trial for IDX21437, a next-generation uridine nucleotide prodrug inhibitor for the treatment of hepatitis C virus infection (HCV) --
Sign-up for Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2013 Financial Results and Provides HCV Pipeline Update investment picks
2014/2/7
CAMBRIDGE, Mass., Feb.
Sign-up for Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference investment picks
2014/1/7
CAMBRIDGE, Mass., Jan.
Sign-up for Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences investment picks
2014/2/26
CAMBRIDGE, Mass., Feb.
Sign-up for Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences investment picks
2014/1/28
CAMBRIDGE, Mass., Jan.
Sign-up for Idenix to Raise $106.7 Million Through Registered Direct Offering investment picks
2014/2/25
NEW YORK (MarketWatch) -- The person behind the @GSElevator Twitter handle has been revealed as a 34-year-old former bond executive living in Texas named John Lefevre, according to a report in The New York Times.
Sign-up for Identity of @GSElevator revealed: report investment picks
2014/3/6
http://media.marketwire.com/attachments/201302/57042_logo-FIDO-gold-alliance02_12_13.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1095572&ProfileId=051205&sourceType=1 FAIRFAX, VA and MOUNTAIN VIEW, CA --
Sign-up for IdentityX Joins FIDO Alliance Board investment picks
2014/3/26
FREMONT, Calif., March 26, 2014 (GLOBE NEWSWIRE) -- Identiv (Nasdaq:INVE) today announced that its CEO, Jason Hart, will participate in a thought leaders panel discussion at Mountain Partners' EntrepreneursDay 2014 in Lake Tegernsee, Germany.
Sign-up for Identiv CEO Jason Hart to Participate in Thought Leaders Panel Discussion on the Internet of Things at EntrepreneursDay 2014 investment picks
2014/4/1
FREMONT, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- Identiv (Nasdaq:INVE) today announced that CEO Jason Hart will lead a presentation at ISC West on establishing trust in the connected world.
Sign-up for Identiv CEO Jason Hart to Present at ISC West on Establishing Trust in the Connected World investment picks
2014/3/31
FREMONT, Calif., March 31, 2014 (GLOBE NEWSWIRE) -- Identiv (Nasdaq:INVE) today announced that it has entered into a $20.0 million term loan and line-of-credit agreement through Opus Bank's Technology Banking Division.
Sign-up for Identiv Raises $20M to Deliver Trust to the Internet of Things investment picks
2014/3/20
FREMONT, Calif., March 20, 2014 (GLOBE NEWSWIRE) -- Identive Group, Inc. (Nasdaq:INVE) reports its financial results for the fourth quarter (Q4) and year ended December 31, 2013.
Sign-up for Identiv Reports Fourth Quarter and Fiscal 2013 Results investment picks
2014/3/19
FREMONT, Calif., March 19, 2014 (GLOBE NEWSWIRE) -- Identive Group, Inc. (Nasdaq:INVE) today announced that it has granted 3,000,000 stock options and 500,000 restricted stock units (RSUs) to Jason D.
Sign-up for Identiv Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) investment picks
2014/3/14
FREMONT, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- Identive Group, Inc. (Nasdaq:INVE) will hold an audio webcast and conference call to discuss the results of its 2013 fourth quarter and year on Thursday, March 20, 2014, at 5:00 PM Eastern time.
Sign-up for Identiv to Hold Fourth Quarter 2013 Conference Call and Webcast March 20, 2014 investment picks
2014/4/2
FREMONT, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Identiv (Nasdaq:INVE) today unveiled its uTrust TS Readers product line.
Sign-up for Identiv Unveils Advanced Open Access uTrust TS Readers investment picks
SANTA ANA, Calif.
Sign-up for Identive Announces New Chairman of the Board and Management Team Promotions investment picks
2013/11/13
SANTA ANA, Calif.
Sign-up for Identive Continues to Simplify and Focus With Plans to Dispose of Non-Core Businesses investment picks
2013/8/14
SANTA ANA, Calif.
Sign-up for Identive Group Announces New Funding From Private Placement investment picks
2013/7/19
-     Investments driving growth in Transponders, NFC and idOnDemand SaaS -       Earnings call and webcast to discuss Q2 results scheduled for August 13, 2013 SANTA ANA, Calif.
Sign-up for Identive Group Provides Preliminary Results for Its 2013 Second Quarter investment picks
- Reaffirmed Preliminary Results Issued on July 19 th - - Investment Strategy Beginning to Deliver Growth in Key Markets With Record Order Book for Next 12 Months - SANTA ANA, Calif.
Sign-up for Identive Group Reports Results for Its 2013 Second Quarter investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case to Identive Group to Hold Second Quarter 2013 Conference Call and Webcast August 14, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity